Lofgren Announces Silicon Valley Company Will Receive Federal Funding to Develop At-Home COVID-19 Test
SAN JOSE, CA – Today, Representative Zoe Lofgren (CA-19) announced that the U.S. Department of Health and Human Services (HHS) will provide Luminostics, Inc. with $718,866 to develop smartphone-based self-testing to detect the coronavirus.
“While the COVID-19 pandemic has brought pain and changed life in Silicon Valley, people are meeting this challenge and doing what they do best – innovating,” said Rep. Lofgren. “It’s no surprise to me that small businesses in the tech sector are advancing our country’s tele-health efforts. It is hoped that this project can help keep our healthcare workers safe, provide relief for cash-strapped local governments, and provide convenience and assurance for families. Grants like this are welcome news, as they help spur our health and economic recovery efforts.”
Luminostics, Inc. is partnering with healthcare company Sanofi to develop the self-testing tool that can detect SARS-CoV-2 – the virus that causes COVID-19 – using respiratory samples. The goal is to eliminate the need for laboratory tests and the administration of diagnostic tests by healthcare professionals. The test, which aims to provide results within 30 minutes, will be based on existing Luminostics technology that requires an iOS/Android device to be paired with an adapter.
This HHS grant is provided specifically through the National Institute of Allergy and Infectious Diseases’ (NIAID) Small Business Innovation Research Grants (SBIR) program, which allocates funds mandated by Congress to improve public health.